Mortality Associated with Infectious Diseases in Dutch Nursing Homes.

Autor: Manyam M; Centre for Infectious Diseases, Epidemiology and Surveillance, Centre for Infectious Disease Control Netherlands, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Electronic address: meghnadhmanyam@gmail.com., Biesheuvel M; Centre for Infectious Diseases, Epidemiology and Surveillance, Centre for Infectious Disease Control Netherlands, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Haenen A; Centre for Infectious Diseases, Epidemiology and Surveillance, Centre for Infectious Disease Control Netherlands, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., van Werkhoven CHH; Centre for Infectious Diseases, Epidemiology and Surveillance, Centre for Infectious Disease Control Netherlands, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands., van de Kassteele J; Centre for Infectious Diseases, Epidemiology and Surveillance, Centre for Infectious Disease Control Netherlands, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., van Gageldonk-Lafeber R; Centre for Infectious Diseases, Epidemiology and Surveillance, Centre for Infectious Disease Control Netherlands, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., de Greeff S; Centre for Infectious Diseases, Epidemiology and Surveillance, Centre for Infectious Disease Control Netherlands, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., van Asten L; Centre for Infectious Diseases, Epidemiology and Surveillance, Centre for Infectious Disease Control Netherlands, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Publikováno v: Journal of the American Medical Directors Association [J Am Med Dir Assoc] 2024 Nov; Vol. 25 (11), pp. 105198. Date of Electronic Publication: 2024 Aug 12.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies

Autor: Rondy, M, Kissling, E, Emborg, HD, Gherasim, A, Meijer, A, van den Brink, S, van der Hoek, W, Goderski, G, Wijsman, L, Bagheri, M, Dijkstra, F, de Lange, M, Marzec, T, Overduin, P, Teirlinck, AC, Donker, G, Marbus, S, van Gageldonk-Lafeber, R

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::2826c7957f33192369096a419249a711
http://hdl.handle.net/10029/623061

Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season

Autor: Rondy, M., Gherasim, A., Casado, I., Launay, O., Rizzo, C., Pitigoi, D., Mickiene, A., Marbus, S. D., Machado, A., Syrjanen, R. K., Pem-Novose, I., Horvath, J. K., Larrauri, A., Castilla, J., Vanhems, P., Alfonsi, V., Ivanciuc, A. E., Kuliese, M., Van Gageldonk-Lafeber, R., Gomez, V., Ikonen, N., Lovric, Z., Ferenczi, A., Moren, A., Pozo, F., Garcia, M., Latorre, M., Omenaca, M., Oribe Amores, M., Munoz, N., Cilla, G., Fernandino, L., Martinez-Baz, I., Navascues, A., Perez-Garcia, A., Aguinaga, A., Ezpeleta, C., Bella, A., Appelgren, E. C., Castrucci, M. R., Puzelli, S., Chironna, M., Germinario, C., Ansaldi, F., Manini, I., Montomoli, E., Lupulescu, E., Lazar, M., Mihai, M. E., Cherciu, C. M., Dinu, S., Tecu, C., Nitescu, M., Bacruban, R., Azamfire, D., Dumitrescu, A., Ianosik, E., Ceausu, E., Popescu, C. P., Florescu, S. A., Tardei, G., Bejan, C., Teodor, A., Juganariu, G., Plesca, C., Duca, E., Lenzi, N., Lesieur, Z., Loulergue, P., Galtier, F., Agostini, C., Ray, M., Merle, C., Foulongne, V., Lina, B., Laine, F., De Guibert, S., Lagathu, G., Tattevin, P., Jouneau, S., Esvant, A., Le Gallou, T., Carrat, F., Mawuvi, G., Chau, F., Nohynek, H., Haveri, A., Gefenaite, G., Velyvyte, D., Jancoriene, L., Zablockiene, B., Ambrozaitis, A., Grimalauskaite, R., Damuleviciene, G., Lesauskaite, V., Bagdonas, A., Nunes, B., Kislaya, I., Rodrigues, A. P., Gomes, V., Corte-Real, R., Pocas, J., Peres, M. J., Bernard, K., Kurecic-Filipovic, S., Visekruna Vucina, V., Topic, A., Papic, N., Budimir, J., Oroszi, B., Meijer, A., Van Der Hoek, W., Schneeberger, P. M.

Publikováno v: Eurosurveillance
Eurosurveillance, 2017, 22 (41), ⟨10.2807/1560-7917.ES.2017.22.41.17-00645⟩
Eurosurveillance, European Centre for Disease Prevention and Control, 2017, 22 (41), ⟨10.2807/1560-7917.ES.2017.22.41.17-00645⟩
Repisalud
Instituto de Salud Carlos III (ISCIII)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Eurosurveillance, European Centre for Disease Prevention and Control, 2017, 22 (41), 〈http://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2017.22.41.17-00645〉. 〈10.2807/1560-7917.ES.2017.22.41.17-00645〉

Members of the I-Move+hospital working group - Portugal: B. Nunes, I. Kislaya, A.P. Rodrigues (National Health Institute Doutor Ricardo Jorge, Lisbon), V. Gomes, R. Côrte-Real (Centro Hospitalar de Lisboa Central, Lisbon), J. Poças, M.J. Peres (Cen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e043247343a74a48a42d3c94b20cf1f
https://doi.org/10.2807/1560-7917.es.2017.22.41.17-00645

Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021.

Autor: Kissling E; Epiconcept, Paris, France., Hooiveld M; Nivel, Utrecht, the Netherlands., Sandonis Martín V; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain., Martínez-Baz I; Instituto de Salud Pública de Navarra (IdiSNA), Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain., William N; Public Health Scotland, Glasgow, Scotland., Vilcu AM; INSERM, Sorbonne Université, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France., Mazagatos C; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain., Domegan L; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., de Lusignan S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Royal College of General Practitioners Research and Surveillance Centre, London, UK., Meijer A; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Machado A; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., Brytting M; The Public Health Agency of Sweden, Stockholm, Sweden., Casado I; Instituto de Salud Pública de Navarra (IdiSNA), Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain., Murray JK; Public Health Scotland, Glasgow, Scotland., Belhillil S; Unité de Génétique Moléculaire des Virus à ARN, UMR 3569 CNRS, Université Paris Diderot SPC, Institut Pasteur, Paris, France.; CNR des virus des infections respiratoires, Institut Pasteur, Paris, France., Larrauri A; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain., O'Donnell J; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Tsang R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Royal College of General Practitioners Research and Surveillance Centre, London, UK., de Lange M; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Rodrigues AP; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., Riess M; The Public Health Agency of Sweden, Stockholm, Sweden., Castilla J; Instituto de Salud Pública de Navarra (IdiSNA), Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain., Hamilton M; Public Health Scotland, Glasgow, Scotland., Falchi A; Laboratoire de Virologie, Université de Corse-Inserm, Corte, France., Pozo F; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain., Dunford L; National Virus Reference Laboratory, University College Dublin, Dublin, Ireland., Cogdale J; Public Health England, London, England., Jansen T; Nivel, Utrecht, the Netherlands., Guiomar R; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., Enkirch T; The Public Health Agency of Sweden, Stockholm, Sweden., Burgui C; Instituto de Salud Pública de Navarra (IdiSNA), Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain., Sigerson D; Public Health Scotland, Glasgow, Scotland., Blanchon T; INSERM, Sorbonne Université, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France., Martínez Ochoa EM; Servicio de Epidemiología y Prevención Sanitaria, Dirección General de Salud Pública, Consumo y Cuidados, La Rioja, Spain., Connell J; National Virus Reference Laboratory, University College Dublin, Dublin, Ireland., Ellis J; Public Health England, London, England., van Gageldonk-Lafeber R; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Kislaya I; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., Rose AM; Epiconcept, Paris, France., Valenciano M; Epiconcept, Paris, France.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2021 Jul; Vol. 26 (29).